CD133+/CD45+BONE MARROW STEM CELLS BOOST LIVER REGENERATION AND SINUSOIDAL VASCULAR RECONSTITUTION IN A CD39-DEPENDENT MANNER

被引：0
|
作者：
Schmelzle, Moritz [1 ,2 ]
Salhanick, Steven [1 ]
Han, Lihui [1 ]
Sun, Xiaofeng [1 ]
Nowak, Martina [1 ]
Csizmadia, Eva [1 ]
Wu, Yan [1 ]
Esch, Jan Schulte Am [2 ]
Knoefel, Wolfram T. [2 ]
Robson, Simon C. [1 ]
机构：
[1] Harvard Univ, Sch Med, Transplant Inst, Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Univ Hosp, Dept Surg, Dusseldorf, Germany
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
315
引用
收藏
页码：478A / 479A
页数：2
相关论文
共 50 条
  • [1] CD39 EXPRESSION ON A SUBSET OF BONE MARROW DERIVED CD133+CD45+STEM CELLS FACILITATES THEIR MOBILIZATION AND PROMOTES LIVER REGENERATION
    Schmelzle, M.
    Duhme, C.
    Junger, W.
    Salhanick, S. D.
    Chen, Y.
    Csizmadia, E.
    Nowak, M.
    Esch, J. Schulte Am
    Knoefel, W. T.
    Robson, S. C.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S21 - S21
  • [2] Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration:: Initial experience
    Fuerst, Guenter
    Esch, Jan Schulte am
    Poll, Ludger W.
    Hosch, Stefan B.
    Fritz, L. Benjamin
    Klein, Michael
    Godehardt, Erhard
    Krieg, Andreas
    Wecker, Britta
    Stoldt, Volker
    Stockschlaeder, Marcus
    Eisenberger, Claus F.
    Moedder, Ulrich
    Knoefel, Wolfram T.
    RADIOLOGY, 2007, 243 (01) : 171 - 179
  • [3] CD133+ bone marrow stem cells (BMSC) control platelet activation - Role of ectoNTPDase-1 (CD39)
    Duhme, Constanze
    Lehwald, Nadja
    Kehrel, Beate E.
    Bauchrowitz, Ellen
    Ngepi, Arlette
    Schmelzle, Moritz
    Kolokotronis, Theodoros
    Benhidjeb, Tahar
    Krueger, Martin
    Jurk, Kerstin
    Knoefel, Wolfram T.
    Robson, Simon C.
    Esch, Jan Schulte am
    BLOOD CELLS MOLECULES AND DISEASES, 2019, 77 : 142 - 148
  • [4] Portal application of autologous CD133+ bone marrow cells to the liver:: A novel concept to support hepatic regeneration
    Esch, JSA
    Knoefel, WT
    Klein, M
    Ghodsizad, A
    Fuerst, G
    Poll, LW
    Piechaczek, C
    Burchardt, ER
    Feifel, N
    Stoldt, V
    Stockschläder, M
    Stoecklein, N
    Tustas, RY
    Eisenberger, CF
    Peiper, M
    Häussinger, D
    Hosch, SB
    STEM CELLS, 2005, 23 (04) : 463 - 470
  • [5] CHARACTERIZATION AND IMAGING OF CD133+ LIVER CANCER STEM CELLS
    Suetsugu, A.
    Osawa, Y.
    Aoki, H.
    Kunisada, T.
    Tsurumi, H.
    Hoffman, R. M.
    Moriwaki, H.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S445 - S446
  • [6] Differentiation of CD133+ bone marrow cells into the mesenchymal lineage.
    Quirici, N
    Soligo, D
    Servida, F
    Deliliers, GL
    BLOOD, 2001, 98 (11) : 84A - 84A
  • [7] CD133+ pluripotent stem cells for the treatment of chronic liver failure
    Lemoli, R.
    Catani, L.
    Lorenzini, S.
    Giordano, R.
    Motta, M. R.
    Giudice, V.
    Sollazzo, D.
    Nicolini, B.
    Montelatici, E.
    Andriolo, G.
    Dan, E.
    Massari, E.
    Baccarani, M.
    Bernardi, M.
    Losinno, F.
    Andreone, P.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S304 - S304
  • [8] Biology and clinical implications of CD133+ liver cancer stem cells
    Ma, Stephanie
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (02) : 126 - 132
  • [9] Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial
    Nasseri, Boris A.
    Ebell, Wolfram
    Dandel, Michael
    Kukucka, Marian
    Gebker, Rolf
    Doltra, Adelina
    Knosalla, Christoph
    Choi, Yeong-Hoon
    Hetzer, Roland
    Stamm, Christof
    EUROPEAN HEART JOURNAL, 2014, 35 (19) : 1263 - 1274
  • [10] CD45dimCD34+CD38−CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia
    Sook-Kyoung Heo
    Eui-Kyu Noh
    Lan Jeong Ju
    Jun Young Sung
    Yoo Kyung Jeong
    Jaekyung Cheon
    Su Jin Koh
    Young Joo Min
    Yunsuk Choi
    Jae-Cheol Jo
    BMC Cancer, 20
12345